Evidence map›Paper›PMID 36986637›Full record

ArticlePharmaceutics2023

[

Berthold A Nock, Panagiotis Kanellopoulos, Euy Sung Moon, Maritina Rouchota, George Loudos, Sanjana Ballal, Madhav P Yadav, Chandrasekhar Bal, Prashant Mishra, Parvind Sheokand and 2 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Head-to-Head Comparison of SSTR Antagonist [Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Berthold A NockMolecular Radiopharmacy, INRaSTES, NCSR "Demokritos", 15310 Athens, Greece.ORCID 0000-0002-6028-9112
Panagiotis KanellopoulosMolecular Radiopharmacy, INRaSTES, NCSR "Demokritos", 15310 Athens, Greece.
Euy Sung MoonDepartment Chemie, Standort TRIGA, Johannes Gutenberg-Universität Mainz, D-55126 Mainz, Germany.
Maritina RouchotaBIOEMTECH, Lefkippos Attica Technology Park, NCSR "Demokritos", 15310 Athens, Greece.
George LoudosBIOEMTECH, Lefkippos Attica Technology Park, NCSR "Demokritos", 15310 Athens, Greece.
Sanjana BallalDepartment of Nuclear Medicine, AIIMS, Ansari Nagar, New Delhi 110029, India.
Madhav P YadavDepartment of Nuclear Medicine, AIIMS, Ansari Nagar, New Delhi 110029, India.
Chandrasekhar BalDepartment of Nuclear Medicine, AIIMS, Ansari Nagar, New Delhi 110029, India.
Prashant MishraDepartment of Nuclear Medicine, AIIMS, Ansari Nagar, New Delhi 110029, India.ORCID 0000-0003-1386-3721
Parvind SheokandDepartment of Nuclear Medicine, AIIMS, Ansari Nagar, New Delhi 110029, India.
Frank RoeschDepartment Chemie, Standort TRIGA, Johannes Gutenberg-Universität Mainz, D-55126 Mainz, Germany.
Theodosia MainaMolecular Radiopharmacy, INRaSTES, NCSR "Demokritos", 15310 Athens, Greece.ORCID 0000-0002-1123-2486
All India Institute of Medical Sciences Raipur · INNational Centre of Scientific Research "Demokritos" · GRJohannes Gutenberg University Mainz · DE

Funding

International Centers for Precision Oncology (ICPO) Foundation, Wiesbaden, Germany New SST2R-antagonists in the diagnosis of neuroendocrine tumors with PET/CTITM Isotope Technologies Munich SE, Garching, Germany Support via provision of radionuclides and publication fees
6 · The paper itself

Abstract

Aiming to expand the application of the SST

Indexed as

AAZTA5 chelatorAAZTA5-LM4In-111Lu-177neuroendocrine tumorsradionuclide therapysomatostatin subtype 2 receptor (SST2R)-antagonistSPECT imagingtheranostics

Identifiers

PMID36986637
PMCPMC10053881
OpenAlexW4322501155

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.